Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2026-01-04 @ 8:01 PM
Study NCT ID:
NCT00313768
Status:
TERMINATED
Last Update Posted:
2009-09-28
First Post:
2006-04-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-10
First Submit QC Date:
None
Study First Post Date:
2006-04-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2009-09-28
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2009-09-24
Last Update Post Date:
2009-09-28
Last Update Post Date Type:
ESTIMATED